Areteia Therapeutics

This study tested an oral medication called dexpramipexole for people with severe asthma driven by high levels of a specific white blood cell (eosinophils). Over 650 participants took either the drug or a placebo pill for one year to see if it safely reduced the number of serious…

This study aimed to check the long-term safety of an experimental drug called dexpramipexole for adults with severe eosinophilic asthma. It enrolled 509 participants who had already completed one of two earlier Phase 3 trials. The main goal was to monitor for side effects and cha…

This study tested whether an oral medication called dexpramipexole could help control severe asthma in people with a specific type called eosinophilic asthma. Over 1,000 participants aged 12 and up, whose asthma was not well-controlled despite standard medications, took either th…